Skip to main content
Clinical Trials/CTRI/2024/06/068684
CTRI/2024/06/068684Not yet recruitingPhase 2

A CONTROLLED THREE ARM CLINICAL STUDY TO ASSES THE EFFICACY OF NITYAVIRECHANA IN HYPOTHYROIDISm

Dr Sudha0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • a)Subjects between 15-55 years of either sex.
  • b)Subject with controlled Diabetes (HbA1C up to 8) and Hypertension (140/100mmHg).
  • c)Subjects of ypothyroidism presenting features mentioned in diagnostic criteria.
  • d)Subjects fit for Virechana Karma.

Exclusion Criteria

  • a)Subjects who do not full fill inclusion criteria will be excluded.
  • b)Subjects with Cardiac disorders, Thyrotoxicosis, Congenital Anomalies, Carcinomas of Thyroid Gland, and Myxoedema with complications are excluded.
  • c)Subjects associated with any other systemic disorders are excluded.
  • d)Post-operative Hypothyroidism.
  • e)Hypothyroidism in Pregnancy is excluded.

Investigators

Sponsor
Dr Sudha

Similar Trials